20240415 lab meeting_俐妤
-
00:00
1.
index 1
-
00:26
2.
Slide 2
-
01:29
3.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
-
02:28
4.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
-
03:02
5.
Slide 5
-
03:05
6.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
-
03:24
7.
Slide 5
-
04:15
8.
Slide 6
-
04:54
9.
Slide 7
-
06:01
10.
Slide 8
-
06:34
11.
Prostate Cancer (PC)
-
07:21
12.
Genetic Alterations and Treatment Approaches of PC
-
08:08
13.
Mechanism of Androgen Receptor (AR)
-
08:47
14.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
-
09:22
15.
Prostate Cancer Resistance Mechanisms
-
10:05
16.
Heterogeneous Patterns of Resistance Mechanisms
-
10:52
17.
Biological Functions of Long Non-coding RNA (lncRNA)
-
11:35
18.
Slide 16
-
12:12
19.
IRX4-AS1 Upregulated in Prostate Cancer
-
13:30
20.
The Characteristic of IRX4-AS1
-
14:37
21.
IRX4-AS1 had Lower Protein Coding Probability
-
15:21
22.
Slide 20
-
15:48
23.
Knockdown IRX4-AS1 Inhibit Cell Proliferation
-
16:25
24.
Knockdown IRX4-AS1 Increased Cell Viability after SG-ARA Treatment
-
17:01
25.
Slide 23
-
17:31
26.
IRX4-AS1 has Binding Potential with AR
-
18:12
27.
IRX4-AS1 didn’t bind with AR
-
18:58
28.
IRX4-AS1 has Binding Potential with miRNA
-
19:47
29.
Slide 27
-
20:05
30.
Knockdown IRX4-AS1 Increased the Level of AR mRNA and AR Protein
-
21:16
31.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
-
21:58
32.
The Characteristic of C4-2 SG-ARA resistant
-
23:18
33.
The Characteristic of C4-2 SG-ARA resistant
-
23:34
34.
IRX4-AS1 downregulated in SG-ARA resistant cells
-
24:10
35.
Slide 33
-
24:28
36.
Slide 34
-
25:47
37.
Thank you for listening
-
26:12
38.
Slide 34
-
26:45
39.
Genetic Alterations and Treatment Approaches of PC
-
28:28
40.
Mechanism of Androgen Receptor (AR)
-
28:31
41.
Prostate Cancer Resistance Mechanisms
-
28:56
42.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
-
28:56
43.
Mechanism of Androgen Receptor (AR)
-
28:56
44.
Genetic Alterations and Treatment Approaches of PC
-
28:57
45.
Prostate Cancer (PC)
-
28:57
46.
Slide 8
-
28:58
47.
Slide 7
-
29:00
48.
Slide 6
-
29:06
49.
Slide 5
-
29:20
50.
Slide 7
-
30:30
51.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
-
35:02
52.
IRX4-AS1 didn’t bind with AR
-
36:24
53.
IRX4-AS1 downregulated in SG-ARA resistant cells
-
38:23
54.
Slide 7
-
39:08
55.
Prostate Cancer (PC)
-
40:56
56.
** after 20240430_林俐妤seminar_V2-3.pptx
-
00:00
1.
index 1
-
00:26
2.
Slide 2
-
01:29
3.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
-
02:28
4.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
-
03:02
5.
Slide 5
-
03:05
6.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
-
03:24
7.
Slide 5
-
04:15
8.
Slide 6
-
04:54
9.
Slide 7
-
06:01
10.
Slide 8
-
06:34
11.
Prostate Cancer (PC)
-
07:21
12.
Genetic Alterations and Treatment Approaches of PC
-
08:08
13.
Mechanism of Androgen Receptor (AR)
-
08:47
14.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
-
09:22
15.
Prostate Cancer Resistance Mechanisms
-
10:05
16.
Heterogeneous Patterns of Resistance Mechanisms
-
10:52
17.
Biological Functions of Long Non-coding RNA (lncRNA)
-
11:35
18.
Slide 16
-
12:12
19.
IRX4-AS1 Upregulated in Prostate Cancer
-
13:30
20.
The Characteristic of IRX4-AS1
-
14:37
21.
IRX4-AS1 had Lower Protein Coding Probability
-
15:21
22.
Slide 20
-
15:48
23.
Knockdown IRX4-AS1 Inhibit Cell Proliferation
-
16:25
24.
Knockdown IRX4-AS1 Increased Cell Viability after SG-ARA Treatment
-
17:01
25.
Slide 23
-
17:31
26.
IRX4-AS1 has Binding Potential with AR
-
18:12
27.
IRX4-AS1 didn’t bind with AR
-
18:58
28.
IRX4-AS1 has Binding Potential with miRNA
-
19:47
29.
Slide 27
-
20:05
30.
Knockdown IRX4-AS1 Increased the Level of AR mRNA and AR Protein
-
21:16
31.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
-
21:58
32.
The Characteristic of C4-2 SG-ARA resistant
-
23:18
33.
The Characteristic of C4-2 SG-ARA resistant
-
23:34
34.
IRX4-AS1 downregulated in SG-ARA resistant cells
-
24:10
35.
Slide 33
-
24:28
36.
Slide 34
-
25:47
37.
Thank you for listening
-
26:12
38.
Slide 34
-
26:45
39.
Genetic Alterations and Treatment Approaches of PC
-
28:28
40.
Mechanism of Androgen Receptor (AR)
-
28:31
41.
Prostate Cancer Resistance Mechanisms
-
28:56
42.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
-
28:56
43.
Mechanism of Androgen Receptor (AR)
-
28:56
44.
Genetic Alterations and Treatment Approaches of PC
-
28:57
45.
Prostate Cancer (PC)
-
28:57
46.
Slide 8
-
28:58
47.
Slide 7
-
29:00
48.
Slide 6
-
29:06
49.
Slide 5
-
29:20
50.
Slide 7
-
30:30
51.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
-
35:02
52.
IRX4-AS1 didn’t bind with AR
-
36:24
53.
IRX4-AS1 downregulated in SG-ARA resistant cells
-
38:23
54.
Slide 7
-
39:08
55.
Prostate Cancer (PC)
-
40:56
56.
** after 20240430_林俐妤seminar_V2-3.pptx
- 位置
-
- 資料夾名稱
- 2024
- 發表人
- 周楷軒
- 單位
- 賴亮全教授
- 建立
- 2024-04-15 09:56:47
- 最近修訂
- 2024-04-15 10:16:21
- 長度
- 41:05